Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 5, 2004, Pages 926-931

  Van Den Goor, J ^a   Nieuwland, R ^a   Van Den Brink, A ^a   Van Oeveren, W ^b   Rutten, P ^a   Tijssen, J ^a   Eijsman, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HaemoScan   (Netherlands)

Author keywords

Acute phase response; Cardiopulmonary bypass; Coronary artery bypass grafting; Inflammatory response

Indexed keywords

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; HEART SURGERY; HUMAN; INFLAMMATION; ORGAN PERFUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REDUCTION; SURGICAL INJURY;

ACUTE-PHASE REACTION; ADULT; AGED; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PANCREATIC ELASTASE; PHOSPHOLIPASES A; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SURFACE PROPERTIES; TRILLIUM;

EID: 7244231258     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.07.035     Document Type: Article

References (21)

1. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur J Cardiothorac Surg 21 2002 232 244
2. S. Wan, J.L. LeClerc, and J.L. Vincent Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies Chest 112 1997 676 692
3. E. Fransen, J. Maessen, M. Dentener, M. Senden, G. Geskes, and W. Buurman Systemic inflammation present in patients undergoing CABG without extracorporeal circulation Chest 113 1998 1290 1295
4. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh, P.G. Jansen, F.W. van Hardevelt, E.M. de Beaumont, C.R. Wildevuur, L. Eijsman, A. Trouwborst, and C.E. Hack Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
5. C.E. Hack, G.J. Wolbink, C. Schalkwijk, H. Speijer, W.T. Hermens, and H. van den Bosch A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells Immunol Today 18 1997 111 115
6. M. Tulunay, S. Demiralp, S. Tastan, H. Akalin, U. Ozyurda, T. Corapcioglu, and E.S. Akarsu Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration Anaesth Intensive Care 21 1993 50 55
7. J.K. Kirklin, S. Westaby, E.H. Blackstone, J.W. Kirklin, D.E. Chenoweth, and A.D. Pacifico Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 1983 845 857
8. J.K. Kirklin Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass Ann Thorac Surg 51 1991 529 531
9. N.E. Moat, D.F. Shore, and T.W. Evans Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins Eur J Cardiothorac Surg 7 1993 563 573
10. H. Baumann, and J. Gauldie The acute phase response Immunol Today 15 1994 74 80
11. P. Bruins, H. te Velthuis, P.G. Jansen, L. Eijsman, and C.E. Hack Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypass J Thorac Cardiovasc Surg 115 1998 949 951
12. Y.J. Gu, W. van Oeveren, C. Akkerman, P.W. Boonstra, R.J. Huyzen, and C.R. WIldevuur Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 1993 917 922
13. E. Fosse, O. Moen, E. Johnson, G. Semb, V. Brockmeier, T.E. Mollnes, M.K. Fagerhol, and P. Venge Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass Ann Thorac Surg 58 1994 472 477
14. M. Levy, and A.R. Hartman Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not Int J Cardiol 53 1996 81 87
15. F. Collart, T. Caus, C. Pomane, V. Pellissier, Y. Chi, J.R. Montis, and T. Mesana Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study Artif Organs 24 2000 611 613
16. V. Videm, T.E. Mollnes, E. Fosse, B. Mohr, K. Bergh, T.A. Hagve, A.O. Aasen, and J.L. Svennevig Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population J Thorac Cardiovasc Surg 117 1999 794 802
17. H. Nakamura, D.K. Kim, D.M. Philbin, M.B. Peterson, F. Debros, G. Koski, and J.V. Bonventre Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery J Clin Invest 95 1995 1062 1070
18. W.C. Oliver Jr, G.A. Nuttall, M.H. Ereth, P.J. Santrach, D.A. Buda, and H.V. Schaff Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 17 2003 165 170
19. V. Videm, J.L. Svennevig, E. Fosse, G. Semb, A. Osterud, and T.E. Mollnes Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
20. D.E. Chenoweth, S.W. Cooper, T.E. Hugli, R.W. Steward, E.H. Blackstone, and J.W. Kirklin Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins N Engl J Med 304 1981 497 503
21. J. de Haan, P.W. Boonstra, N. Tabuchi, W. van Oeveren, and T. Ebels Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit J Thorac Cardiovasc Surg 111 1996 272 275